Hypothalamic control of lipid metabolism. - Suppr | 超能文献

Hypothalamic control of lipid metabolism.

作者信息

Schwandt P

出版信息

Acta Neurochir (Wien). 1985;75(1-4):122-4. doi: 10.1007/BF01406332.

DOI:10.1007/BF01406332

Abstract

Obesity as a common disorder of lipid metabolism might be caused by defective hypothalamic control as demonstrated by ventromedial lesions or the effect of cholecystokinin application. The hypothalamic proopiomelanocorticotropin is the precursor of hormonal fragments affecting fat mobilisation, the endocrine pancreas and gastrointestinal functions.

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Hypothalamic control of lipid metabolism.

Acta Neurochir (Wien). 1985;75(1-4):122-4. doi: 10.1007/BF01406332.

2

[Regulation of food intake by the central nervous system and the gastro-intestinal tract].

Leber Magen Darm. 1986 Jan;16(1):28-34.

3

Effects of pro-opiomelanocortin-derived peptides on plasma levels of glucagon, insulin and glucose.

Horm Metab Res. 1986 Sep;18(9):579-83. doi: 10.1055/s-2007-1012379.

4

Interactions between gastric emptying and satiety, with special reference to glucagon-like peptide-1.

Physiol Behav. 2001 Nov-Dec;74(4-5):735-41. doi: 10.1016/s0031-9384(01)00618-7.

5

Role of cholecystokinin and opioid peptides in control of food intake.

Physiol Rev. 1986 Jan;66(1):172-234. doi: 10.1152/physrev.1986.66.1.172.

6

Cholecystokinin and satiety: effect of hypothalamic obesity and gastric bubble insertion.

Am J Physiol. 1992 Feb;262(2 Pt 2):R241-4. doi: 10.1152/ajpregu.1992.262.2.R241.

7

Beta-endorphin and the endocrine pancreas. Studies in healthy and diabetic human beings.

N Engl J Med. 1983 Feb 17;308(7):349-53. doi: 10.1056/NEJM198302173080701.

8

[The YY3-36 peptide, a new therapeutic weapon against obesity?].

Med Sci (Paris). 2003 May;19(5):537-9. doi: 10.1051/medsci/2003195537.

9

Opioid peptide processing and receptor selectivity.

Annu Rev Pharmacol Toxicol. 1986;26:59-77. doi: 10.1146/annurev.pa.26.040186.000423.

10

[New data on the role of cerebrointestinal peptides in appetite regulation and control of obesity].

Pediatriia. 1984 May(5):45-8.

引用本文的文献

1

Synthetic ACTH for Treatment of Glomerular Diseases: A Case Series.

Can J Kidney Health Dis. 2022 Jan 5;9:20543581211066979. doi: 10.1177/20543581211066979. eCollection 2022.

2

Leveraging melanocortin pathways to treat glomerular diseases.

Adv Chronic Kidney Dis. 2014 Mar;21(2):134-51. doi: 10.1053/j.ackd.2013.09.004.

本文引用的文献

1

Simple automated system for continuous-flow determination of glycerol.

Clin Chem. 1981 Mar;27(3):512.

2

Brain cholecystokinin in fasted and fed mice.

Life Sci. 1980 Mar 24;26(12):969-70. doi: 10.1016/0024-3205(80)90118-6.

3

The role of vagally-medicated hyperinsulinemia in hypothalamic obesity.

Neurosci Biobehav Rev. 1982 Summer;6(2):205-14. doi: 10.1016/0149-7634(82)90056-2.

4

Naloxone decreases food intake in obese humans.

J Clin Endocrinol Metab. 1982 Jul;55(1):196-8. doi: 10.1210/jcem-55-1-196.

5

beta-Lipotropin increases plasma insulin immunoreactivity.

Life Sci. 1981 Jul 27;29(4):345-9. doi: 10.1016/0024-3205(81)90327-1.

6

beta-Endorphin stimulates the secretion of insulin and glucagon in humans.

J Clin Endocrinol Metab. 1981 Mar;52(3):592-4. doi: 10.1210/jcem-52-3-592.

7

Peripheral insulin in response to the sight and smell of food.

Metabolism. 1980 Oct;29(10):901-9. doi: 10.1016/0026-0495(80)90031-1.

8

Evidence that the insulin secretagogue, beta-cell-tropin, is ACTH22-39.

Nature. 1983 Jan 20;301(5897):255-8. doi: 10.1038/301255a0.

9

Beta-endorphin and the endocrine pancreas. Studies in healthy and diabetic human beings.

N Engl J Med. 1983 Feb 17;308(7):349-53. doi: 10.1056/NEJM198302173080701.

10

Opiate receptor blockade in man reduces 2-deoxy-D-glucose-induced food intake but not hunger, thirst, and hypothermia.

Life Sci. 1982 Aug 30;31(9):847-52. doi: 10.1016/0024-3205(82)90539-2.